Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENDO - Bowel ENDOmetriosis; Evaluation of Diagnostics and Quality of Life (ENDO1, ENDO2, ENDO3)

NCT03779256 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT03779256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03779256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENDO - Bowel ENDOmetriosis; Evaluation of Diagnostics and Quality of Life (ENDO1, ENDO2, ENDO3)
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Completed
Start date
December 10, 2018
Completion date
March 8, 2021
Enrollment
207 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bowel dysfunction, deep endometriosis, deep infiltrating endometriosis, endometriosis rectum, endometriosis related pain, pain, chronic, quality of life